Drawing for XLEAP-SBS

USPTO serial 97796799

XLEAP-SBS

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
RILEY, KATHERINE M
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with XLEAP-SBS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan M. Natland

Susan M. Natland Baker & Hostetler LLP600 Anton Blvd, Suite 900Costa Mesa, CA 92626-7221United States

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for use in cell cultures other than for medical and veterinary purposes; Biological preparations for use in industry, and science; Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of genotyping, medical research, veterinary research, dental research, clinical research, metagenomics, biotechnology, drug development research, disease treatment research, pharmaceutical research, dietary supplement research, fungicide research, herbicide research, medical laboratory research, veterinary science, life sciences, biology, microbiology, agriculture, forensics, food safety, cosmetics, dermatology, genetic testing, nucleic acid sequencing, genetics, oncology, prenatal screening and testing, diseases, in vitro diagnostic research, infectious diseases, reproductive health, neonatal intensive care, and personalized medicine, not for medical or veterinary purposes; Kits containing nucleotides, reagents, enzymes, enzyme substrates, agents, assays, buffers, chemical preparations, and biological preparations for use thereof for non-medical purposes; Kits comprising nucleotides, reagents, enzymes, enzyme substrates, agents, assays, buffers, chemical preparations and biological preparations for scientific and research use in the fields of genotyping, medical research, veterinary research, dental research, clinical research, metagenomics, biotechnology, drug development research, disease treatment research, pharmaceutical research, dietary supplement research, fungicide research, herbicide research, medical laboratory research, veterinary science, life sciences, biology, microbiology, agriculture, forensics, food safety, cosmetics, dermatology, genetic testing, nucleic acid sequencing, genetics, oncology, prenatal screening and testing, diseases, in vitro diagnostic research, infectious diseases, reproductive health, neonatal intensive care, and personalized medicine, not for medical or veterinary purposes; Chemical test kits for laboratory or research use, namely, for use in industry, science, medical research, photography, agriculture, aquaculture, horticulture and forestryACTIVE—
005Diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations nucleic acid sequencing, genotyping, genetics, and metagenomics, and biological preparations for nucleic acid sequencing, genotyping, genetics, and metagenomics, all for medical and veterinary use; Diagnostic reagents and preparations for medical, dental, and veterinary use; Clinical medical diagnostic reagents; Biological preparations for nucleic acid sequencing, genotyping, genetics, and metagenomics, all for medical, dental, and veterinary use; Chemical and biological preparations for use in the treatment of illness and disease being biological and chemical preparations, agents, reagents, assays, enzymes, nucleotides, and buffers, for nucleic acid sequencing, genotyping, genetics, and metagenomics, all for medical, dental, and veterinary purposes; Bacterial preparations for medical, dental and veterinary use; Biological tissue cultures for medical, dental, and veterinary use; Blood for medical purposes; Parasiticides; Kits comprised of nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for medical purposes; Kits comprised of nucleotides, reagents, enzymes, agents, assays buffers, and chemical and biological preparations for nucleic acid sequencing, genotyping, genetics, and metagenomics, all for medical genetic testing and medical diagnostic purposes; Agents, reagents, assays for testing body fluids for microorganisms, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for nucleic acid sequencing, genotyping, genetics, and metagenomics, all for medical, dental and veterinary use in the fields of medical diagnostics, clinical diagnostics, companion diagnostics, veterinary diagnostics, dental diagnostics, medical forensics, laboratory medicine, veterinary medicine, genetic testing, nucleic acid sequencing, genetics, cosmetics, dermatology, oncology, prenatal screening and testing, diseases, forensics, in vitro diagnostics, infectious diseases, reproductive health, neonatal intensive care, personalized medicine, microbiology, biology, biotechnology, metagenomics, pharmaceuticals, dietary supplements, fungicide development, herbicide development, and drug development; Kits comprised of enzyme substrates for medical genetic testing and medical diagnostic purposesACTIVE—
009Downloadable data compression and decompression software; Downloadable computer software for use in copying, deleting, comparing, managing, organizing, compressing, decompressing, restoring, repairing, creating, storing, synchronizing, securing and archiving of data and files; Downloadable software for copying, deleting, comparing, managing, organizing, compressing, decompressing, restoring, repairing, creating, storing, synchronizing, securing and archiving of data for use in the fields of diagnostics, companion diagnostics, medical diagnostics, medical treatment, medical research, clinical diagnostics, clinical research, veterinary diagnostics, veterinary research, medical forensics, medical laboratory research, laboratory medicine, veterinary medicine, veterinary science, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, agriculture, food safety, cosmetics, dermatology, oncology, prenatal screening and testing, diseases, forensics, in vitro diagnostics, infectious diseases, reproductive health, neonatal intensive care, personalized medicine, microbiology, biology, biotechnology, metagenomics, pharmaceuticals, dietary supplements, dietary supplement development, fungicide development, herbicide development, drug development and disease treatment; Downloadable computer software for compressing and decompressing genomic data files; Apparatus and instruments for scientific research in laboratories, namely, genetic sequencers; Laboratory devices for detecting genetic sequences; Diagnostic apparatus for the detection of pathogens for laboratory or research use; Scientific and research apparatus and instruments, namely, genetic sequencers for use in the fields of diagnostics, companion diagnostics, medical diagnostics, medical treatment, medical research, clinical diagnostics, clinical research, veterinary diagnostics, veterinary research, dental research, medical forensics, medical laboratory research, laboratory medicine, veterinary medicine, veterinary science, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, agriculture, food safety, cosmetics, dermatology, oncology, prenatal screening and testing, diseases, forensics, in vitro diagnostics, infectious diseases, reproductive health, neonatal intensive care, personalized medicine, microbiology, biology, biotechnology, metagenomics, pharmaceuticals, dietary supplements, dietary supplement development, fungicide development, herbicide development, drug development and disease treatment; Apparatus for DNA and RNA testing for research purposes; Scientific apparatus and instruments for measuring DNA, RNA and protein and parts and fittings therefor; Medical laboratory research instruments for DNA and RNA analysis; Apparatus and instruments for testing gas, liquids, and solids; DNA chips; Computer hardware; Data processing apparatus; Computers; Computer peripheral devices; Downloadable software for scientific analysis of genetic sequences; Computer hardware with embedded operating system software for scientific analysis of genetic sequences; Computer hardware for use with medical patient monitoring equipment, for copying, deleting, comparing, managing, organizing, compressing, decompressing, restoring, repairing, creating, storing, synchronizing, securing and archiving of data, for use in the fields of diagnostics, companion diagnostics, medical diagnostics, medical research, medical treatment, clinical diagnostics, clinical research, veterinary diagnostics, veterinary research, dental research, medical forensics, medical laboratory research, laboratory medicine, veterinary medicine, veterinary science, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, agriculture, food safety, cosmetics, dermatology, oncology, prenatal screening and testing, diseases, forensics, in vitro diagnostics, infectious diseases, reproductive health, neonatal intensive care, personalized medicine, microbiology, biology, biotechnology, metagenomics, pharmaceuticals, dietary supplements, dietary supplement development, fungicide development, herbicide development, drug development and disease treatment; Downloadable software for storing, organizing and creating a searchable library of genetic data for use in sequence detection, and disease detection, diagnosis and treatment; Downloadable software for database management and for storage of electronic data; Downloadable software for creating searchable databases of information and data; Downloadable databases in the field of genetics; Scientific and research apparatus and instruments, namely, nucleic acid sequencers for scientific purposes, nucleic acid arrays, scanners being nucleic acid array scanners, electronic imaging devices and analyzers, testing sample collection equipment, namely, wipes and swabs for use in diagnostic testing, not for medical purposes, and sample quality control instruments being laboratory devices for detecting genetic sequencing, sequencing reagent cartridges and laboratory trays, and test sample preparation equipment being laboratory tools and supplies, for laboratory use; Laboratory trays; Next-generation sequencing (NGS) bioinformatics data processor; Downloadable computer application software, namely, software to receive and store DNA, RNA and genetic records, and to authorize medical and research personnel to use records; Downloadable electronic publications in the nature of manuals, instruction booklets, brochures, and newsletters in the fields of diagnostics, companion diagnostics, medical diagnostics, medical research, medical treatment, clinical diagnostics, clinical research, veterinary diagnostics, veterinary research, dental research, medical forensics, medical laboratory research, laboratory medicine, veterinary medicine, veterinary science, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, agriculture, food safety, cosmetics, dermatology, oncology, prenatal screening and testing, diseases, forensics, in vitro diagnostics, infectious diseases, reproductive health, neonatal intensive care, personalized medicine, microbiology, biology, biotechnology, metagenomics, pharmaceuticals, dietary supplements, dietary supplement development, fungicide development, herbicide development, drug development and disease treatment; Downloadable electronic reports in the fields of diagnostics, companion diagnostics, medical diagnostics, medical treatment, medical research, clinical diagnostics, clinical research, veterinary diagnostics, veterinary research, medical forensics, medical laboratory research, laboratory medicine, veterinary medicine, veterinary science, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, agriculture, food safety, cosmetics, dermatology, oncology, prenatal screening and testing, diseases, forensics, in vitro diagnostics, infectious diseases, reproductive health, neonatal intensive care, personalized medicine, microbiology, biology, biotechnology, metagenomics, pharmaceuticals, dietary supplements, dietary supplement development, fungicide development, herbicide development, drug development and disease treatment; Downloadable computer software for compressing and decompressing data and files; Downloadable computer software for encrypting data and files; Downloadable computer software for maximizing data and file storage; Downloadable computer software for use in file compression, file decompression, archiving, and computer file management; Downloadable computer software for accessing and decompressing archives stored in files, and then viewing and downloading one or more decompressed individual files stored inside the original compressed files archive; Downloadable computer software for creating a compressed file archive containing one or more user-selected individual files; Computer chips; Microprocessors; Integrated circuits; Cards with integrated circuits; Encoded electronic chip cards containing programming used for DNA sequencing; Apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; Apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; Medical apparatus and instruments, namely genetic sequencersACTIVE—
010Medical apparatus and instruments, namely, genetic testing apparatus in the nature of genetic sequencers; Medical diagnostic apparatus and instruments for detecting genetic sequences; Medical diagnostic apparatus for use in detecting pathogens; Medical diagnostic apparatus and instruments for the analysis of body fluids; Apparatus for blood analysis; Apparatus for DNA and RNA testing for medical purposes; Medical, dental and veterinary apparatus and instruments, namely, genetic testing apparatus in the nature of genetic sequencers, for use in the fields of genotyping, medical diagnostics, companion diagnostics, veterinary diagnostics, dental diagnostics, clinical diagnostics, medical treatment, medical research, veterinary research, diagnostics, clinical research, metagenomics, biotechnology, drug development, disease treatment, pharmaceuticals, dietary supplements, dietary supplement development, fungicide development, herbicide development, medical laboratory research, veterinary science, life sciences, biology, microbiology, agriculture, forensics, food safety, cosmetics, dermatology, genetic testing, nucleic acid sequencing, and genetics, oncology, prenatal screening and testing, diseases, in vitro diagnostics, infectious diseases, reproductive health, neonatal intensive care, and personalized medicine; Genetic testing apparatus for medical purposes; Medical diagnostic apparatus and instruments for use in preparing blood, bodily fluid and human biological samples for further testing and for the detection and identification of pathogen nucleic acids in blood, bodily fluids and biological samples; Clinical and medical apparatus and instruments, namely, nucleic acid sequencers, nucleic acid array scanners, imaging devices, and sample and library preparation devices for use in the fields of genotyping, medical diagnostics, companion diagnostics, veterinary diagnostics, dental diagnostics, clinical diagnostics, medical treatment, medical research, veterinary research, diagnostics, clinical research, metagenomics, biotechnology, drug development, disease treatment, pharmaceuticals, dietary supplements, dietary supplement development, fungicide development, herbicide development, medical laboratory research, veterinary science, life sciences, biology, microbiology, agriculture, forensics, food safety, cosmetics, dermatology, genetic testing, nucleic acid sequencing, and genetics, oncology, prenatal screening and testing, diseases, in vitro diagnostics, infectious diseases, reproductive health, neonatal intensive care, and personalized medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 5, 2026EX2GSOU EXTENSION 2 GRANTED—
Oct 5, 2026EXT2SOU EXTENSION 2 FILED—
Oct 5, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 2, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 1, 2026EX1GSOU EXTENSION 1 GRANTED—
Apr 1, 2026EXT1SOU EXTENSION 1 FILED—
Apr 1, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 29, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 29, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 29, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 29, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 29, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 29, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 7, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 10, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 10, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 4, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 8, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 8, 2025XAECEXAMINER'S AMENDMENT ENTERED—
May 8, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 8, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
May 8, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 11, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 11, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 11, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 13, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 12, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 15, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 15, 2024ALIEASSIGNED TO LIE—
May 29, 2024DOCKASSIGNED TO EXAMINER—
Feb 29, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 29, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2023DOCKASSIGNED TO EXAMINER—
Mar 6, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 18, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance